Author(s)

MengYao Hu, JingCan Zhuang, XingYu Shao, XinYu Ren,Yu Chen, YuMei Jiao, Lei Liu^*

Affiliation(s)

College of Integrated Chinese and Western Medicine, Jining Medical University, Jining 272067, Shandong, China.

Corresponding Author

Lei Liu

ABSTRACT

Cancer worldwide has a high incidence rate and a high case fatality rate, causing a serious disease burden on humans. It is of great significance to slow down the risk of cancer, to study the treatment of cancer and to clarify the target of cancer to improve the prognosis of patients with cancer. Chronic inflammation can lead to the occurrence of cancer, and the mechanism of inflammation leading to the occurrence and development of cancer is not very clear. Traditional Chinese medicine (TCM) can prevent inflammatory cancer transformation by inhibiting inflammatory reaction. This paper discusses the mechanism of TCM prevention and treatment of inflammatory cancer transformation, which is helpful to further explain the pharmacological effect of compound TCM prescriptions and active ingredients, in order to provide new ideas for the wider and more accurate application of TCM in clinical practice.

KEYWORDS

Traditional Chinese medicine; Inflammation-cancer transformation; Epithelial-mesenchymal transition; Tumor-associated macrophages; Cancer stem cells

CITE THIS PAPER

MengYao Hu, JingCan Zhuang, XingYu Shao, XinYu Ren,Yu Chen, YuMei Jiao, Lei Liu. Discussion on the mechanism of TCM prevention and treatment of "inflammation-cancer" transformation. Eurasia Journal of Science and Technology. 2024, 6(4): 28-30. DOI: 10.61784/ejst3022.

REFERENCES

[1] Qi J, Li M, Wang L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023, 8(12): e943-e955.

[2] SHEN Jialin, ZHAO Xiaoying, XIAO Haijuan. Mechanisms of Si Junzitang and Its Main Active Components in Treating Colorectal Cancer: A Review. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30 (16): 240-252.

[3] Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature, 2012, 481(7381): 278-286.

[4] Huang L, Luo R, Li J, et al. β-catenin promotes NLRP3 inflammasome activation via increasing the association between NLRP3 and ASC. Mol Immunol, 2020, 5(121): 186-194.

[5] ZHANG Qijun, YIN Shumin, CHE Yong, et al. Effect of Feiyanning Formula on Tumor-Infiltrating Myeloid Cells of Mice with Lewis Lung Cancer. Acta Chinese Medicine and Pharmacology, 2021, 49 (12): 34-40.

[6] LUO Yang, TONG Bing-jie, ZHAO Bin, et al. Chutan-Jiedu decoction reverses resistance of lung cancer to gefitinib by processing EMT. Chinese Journal of Pathophysiology, 2019, 35(01): 34-40.

[7] LUO Yang, WANG Shu-mei, TONG Bing-jie, et al. Effects of Chutan Jiedu Decoction Combined with Gefitinib on the Expressions of Twist and Fibronectin in Nude Mouse Xenografts Models of H1975 Human Lung Adenocarcinoma. Natural Product Research and Development, 2018, 30(08): 1319-1324+1366.

[8] QIN Yuanyuan, ZHU Lingyan, LI Li, et al. Effect of Qinghua Yichang Formula on NLRP3 Inflammasome in Intestinal Tissue of Mice with Acute Radiation-Induced Intestinal Injury. Journal of Traditional Chinese Medicine, 2024, 65(16): 1695-1702.

[9] Cheng H, Ge X, Zhuo S, et al. β-Elemene Synergizes With tinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2. Front Pharmacol, 2018, 9: 1413.

[10] Adjei I M, Blanka S. Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater, 2015, 6(1): 81-103.

[11] ZHAO Xing-hao, YANG Qi, JIANG Xiao, et al. Research Progress on Prevention and Treatment of Liver Cancer by Invigorating Spleen. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 2019, 25(23): 106-108.

[12] YANG Yi, HU Yan-e, HUANG Yu-qing, et al. Tongxie Yaofang regulates tumor-associated macrophage polarization in colorectal cancer under chronic stress. China Journal of Chinese Materia Medica, 2023, 48(22): 6142-6153. 

[13] YANG Limei, ZhANG Yingru, YU Hao, et al. Effect of coix seed on the development of colon cancer in colitis cancer transformation model mice by regulating NF- κ B signaling pathway. Chinese Traditional Patent Medicine, 2023, 45(12): 4131-4136.

[14] LIU Bo, ZHANG Chuan-feng, MA Ke-long, et al. Mechanism of Action of Paeonol in Alleviating Colitis-related Colorectal Cancer in Mice:An Analysis Based on the STAT-3/NF-κB/ICAM-1 Pathway. Journal of Anhui University of Chinese Medicine, 2021, 40(01): 88-92.

[15] Martínez-Ramírez AS, Díaz-Munoz M, Butanda-Ochoa A, et al. Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT). Purinergic Signal, 2017, 13(1): 1-12.

[16] Cao L, Yang Y, Ye Z, et al. Quercetin-3-methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways. International Journal of Molecular Medicine, 2018, 42(3).

[17] JING Lin-lin,YAO Xue-qing, FU Xiu-qiong, et al. TCM Property and Pathogenesis of Cancer Stem Cells and Niche. Journal of Nanjing University of Traditional Chinese Medicine, 2018, 34(2): 3.

[18] SHEN Zheng-jie, CHENG Hai-bo, SHEN Wei-xing, et al. Correlation between tumor inflammatory microenvironment and “cancerous toxin” pathogenesis. Journal of Beijing University of Traditional Chinese Medicine, 2015, 38(01): 14-17.